Consolidated Balance Sheets - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Current Assets
Cash	$ 33,146,725	$ 3,958,957
Accounts receivable, net	5,277,250	2,834,750
Product deposit	485,850	127,265
Inventory, net	2,759,932	3,703,363
Other current assets	934,510	687,022
Total Current Assets	42,604,267	11,311,357
Non-current Assets
Equipment, net	476,303	476,441
Right of use asset	594,897	1,206,009
Capitalized software, net	11,795,979	8,840,187
Intangible assets, net	3,009,263	3,831,859
Total Non-current Assets	15,876,442	14,354,496
Total Assets	58,480,709	25,665,853
Current Liabilities
Accounts payable	11,084,855	10,106,793
Accrued expenses	13,937,494	12,166,509
Notes payable, net	327,597	2,797,250
Current operating lease liabilities	603,180	756,093
Deferred revenue	8,828,598	5,547,506
Total Current Liabilities	34,781,724	31,374,151
Long-term Liabilities
Long-term debt, net	17,927,727
Noncurrent operating lease liabilities	73,849	574,136
Contingent consideration	131,250	443,750
Purchase price payable		579,319
Total Liabilities	52,914,550	32,971,356
Commitments and contingencies (Note 10)
Mezzanine Equity
Preferred Stock, $0.0001 par value; 5,000,000 shares authorized Series B Convertible Preferred Stock, $0.0001 par value; 5,000 shares authorized, zero and 3,500 shares issued and outstanding, liquidation value approximately, $0 and $1,305 per share as of December 31, 2023 and 2022, respectively		4,565,822
Stockholders’ Equity (Deficit)
Series A Preferred Stock, $0.0001 par value; 1,610,000 shares authorized, 1,400,000 shares issued and outstanding, liquidation value approximately, $29.99 and $27.84 per share as of December 31, 2023 and 2022, respectively	140	140
Common Stock, $0.01 par value; 100,000,000 shares authorized, 38,358,641 and 31,552,775 shares issued, 38,255,601 and 31,449,735 outstanding as of December 31, 2023 and 2022, respectively	383,586	315,528
Additional paid-in capital	217,550,583	179,015,250
Accumulated deficit	(214,265,236)	(190,562,994)
Treasury stock, 103,040 and 103,040 shares, at cost, as of December 31, 2023 and 2022, respectively	(163,701)	(163,701)
Total LifeMD, Inc. Stockholders’ Equity (Deficit)	3,505,372	(11,395,777)
Non-controlling interest	2,060,787	(475,548)
Total Stockholders’ Equity (Deficit)	5,566,159	(11,871,325)
Total Liabilities, Mezzanine Equity and Stockholders’ Equity (Deficit)	$ 58,480,709	$ 25,665,853